Ameriprise Financial is a diversified financial services holding company, incorporated in Delaware, whose earliest predecessor, Investors Syndicate, was founded in 1894. It operates through two approaches: wealth management and asset management. Via a network of more than 10,000 financial advisors it provides financial planning and advice, brokerage, managed accounts, and cash management and banking. It distributes annuities and life and disability income insurance under the RiverSource brand, and offers investment products through Columbia Threadneedle Investments.
Its customers include individual, high-net-worth and institutional investors, with more than 3.5 million retail clients; the primary target is households holding between $500,000 and $5,000,000 in investable assets. Much of its income is fee-based and tied to client asset levels, supplemented by planning and transaction fees, distribution fees, net investment income, insurance premiums, and management and performance fees.
The firm reports in four segments: Advice & Wealth Management; Asset Management; Retirement & Protection Solutions; and Corporate & Other. Its investment management arm operates in 16 markets, including France, Germany, Luxembourg, the Netherlands, Singapore, the UK and the US. It employs roughly 13,600 people, works with about 8,500 franchise advisors, and held $1.7 trillion in assets under management, administration and advisement at the end of 2025. It separated from American Express in 2005.
Based on Ameriprise Financial's 10-K filed February 19, 2026.
Loading chart…
Third-party market data · may be delayed
~$510
Valuation models combined (4)
Base case. Range ~$420–$620. Weighted average of 4 models (forward price-to-earnings vs peers, residual income, justified price-to-book, dividend discount (two-stage)), the forward price-to-earnings vs peers counting double.
Modestly undervalued
The price is inside our value range, 2% below our base value.
Price used: $504.31, November 2, 2026
Ameriprise Financial valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Model value +14.7%
Revenue for the twelve months to September 2026 was $20.1bn, up 8.8% on a year earlier, about the same pace as a quarter earlier. The diluted share count is down 5.8% on a year earlier, which lifts each remaining share. Our model value rises from $440 to $504 a share, against a share price of $491. The rating stays Hold.
Source: 10-Q filed October 30, 2026 on SEC EDGAR · Financials · Valuation
Revenue for the twelve months to June 2026 was $19.8bn, up 9.1% on a year earlier, faster than 6.8% a quarter earlier. The diluted share count is down 5.2% on a year earlier, which lifts each remaining share. Our valuation models combined value is $503 a share, against a share price of $485.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Ameriprise Financial's trailing-twelve-month revenue grew 8.8% year on year, with a free-cash-flow margin of 36.4%. Where it stands out: change in share count of -5.8% ranks 3 of 33 asset management & custody banks companies we cover.
Current signal Share count shrinking (buybacks): Diluted shares outstanding fell 5.8% year over year.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
Ameriprise’s quarterly net income rose 23.5%, while operating cash flow fell 33.3%. Wealth management fees supported earnings, but insurance valuation effects complicate the comparison and asset-management outflows persist.
We value Ameriprise Financial as an asset manager, broker or exchange, with every model that fits that kind of business. Cost of equity 9.1%: the 10-year Treasury yield (4.9%) plus a beta of 0.91 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$470 ~$390–$610 | Primary model, counts double |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$420 ~$300–$600 | Included |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$590 ~$510–$710 | Included |
| Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. | ~$83 ~$86–$220 | Left out: out of range vs price (0.16x) |
| Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. | ~$620 ~$510–$770 | Included |
| Combined value Weighted average of the models that apply: the primary model (forward price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$510 ~$420–$620 | 4 models |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Ameriprise Financial with asset managers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Strong moat
How hard Ameriprise Financial's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Net income has been a median 1.6% of total assets over 10 years.
Net margin has been a median 16.9%; its worst year was 13.5%.
The diluted share count fell 22.8% over five years; stock-based pay has been a median 1.1% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (91 before it).
Next results: January 28, 2027, before the open. Analysts expect revenue of $5.2bn and EPS of $12.35 (range $11.97 to $13.29) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $46.44 | +18% | $20.0bn | +9% |
| Next | $51.50 | +11% | $21.2bn | +6% |
Next year's EPS estimate has moved +3.3% in 90 days, across 13 analysts.
The consensus EPS forecast for the current fiscal year is +2.3% on 90 days ago. In the last 30 days, 2 analysts raised Ameriprise Financial's forecast and 4 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $45.40 | $49.85 |
| 60 days ago | $46.44 | $51.54 |
| 30 days ago | $46.53 | $51.67 |
| 7 days ago | $46.47 | $51.63 |
| Now | $46.44 | $51.50 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Sept 2026 | $11.77 | $11.26 | −4.3% |
| Jun 2026 | $10.81 | $11.07 | +2.4% |
| Mar 2026 | $10.21 | $11.26 | +10.2% |
| Dec 2025 | $10.31 | $10.83 | +5.0% |
Adjusted EPS as companies report it, against the average analyst estimate.
Last 12 months +12.9%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $18.2bn | $19.8bn | +9.1% |
| Net margin | 17.7% | 19.9% | +12.2% |
| P/E multiple | 13.9x | 12.2x | −12.6% |
| Share count | 101m | 95m | +5.5% |
Biggest factor: p/e multiple.
Last 3 years +55.7%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $15.0bn | $19.8bn | +32.1% |
| Net margin | 20.1% | 19.9% | −1.0% |
| P/E multiple | 11.9x | 12.2x | +2.6% |
| Share count | 111m | 95m | +16.0% |
Biggest factor: revenue.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| AMP | +58% | +5% | +24% | +42% | −7% | +4% |
| Industry peers (median) | +33% | −17% | +19% | +15% | −4% | −6% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| AMP | 75% | 50% | 42% | 75% | 42% | 55% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| AMP | −11% | −32% | −21% | −12% | −26% | −21% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since November 2, 2015: 54% from February 20, 2020 to March 23, 2020. Getting back needed a 117% gain, reached on November 9, 2020, 231 days after the low.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| October 29, 2026 | +0.2% | −2.1% | — | — |
| July 23, 2026 | +0.4% | −1.1% | +3.3% | +5.8% |
| April 23, 2026 | −0.9% | +0.4% | +1.3% | −3.1% |
| January 29, 2026 | +5.5% | −0.5% | +7.1% | −4.6% |
| October 30, 2025 | −5.4% | −0.8% | −4.4% | −4.6% |
| July 24, 2025 | −3.0% | +0.5% | −3.5% | −3.4% |
| April 24, 2025 | −1.3% | +2.8% | −0.3% | +7.3% |
| January 29, 2025 | −4.2% | +0.1% | −5.9% | −5.8% |
| October 23, 2024 | −3.0% | −0.7% | −1.1% | +10.1% |
| July 24, 2024 | +4.8% | −2.8% | +2.1% | +3.3% |
| April 22, 2024 | −2.2% | +2.1% | −0.2% | +4.5% |
| January 24, 2024 | +0.9% | +0.7% | −0.3% | +5.3% |
How Ameriprise Financial’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.
Not offered: fundamentals grade B (needs B+ or better).
We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.
Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.
For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.
Not offered: the shares trade below our fair value: a collar caps upside the model expects.
For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.
General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.
Source: SEC EDGAR filings. Retrieved November 3, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY23 Q4 | $15.9B |
| FY24 Q1 | $16.4B |
| FY24 Q2 | $16.8B |
| FY24 Q3 | $17.3B |
| FY24 Q4 | $17.9B |
| FY25 Q1 | $18.1B |
| FY25 Q2 | $18.2B |
| FY25 Q3 | $18.5B |
| FY25 Q4 | $18.9B |
| FY26 Q1 | $19.3B |
| FY26 Q2 | $19.8B |
| FY26 Q3 | $20.1B |
Source: SEC EDGAR filings. Retrieved November 3, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY23 Q4 | 11.5% |
| FY24 Q1 | 13.1% |
| FY24 Q2 | 11.8% |
| FY24 Q3 | 10.8% |
| FY24 Q4 | 12.6% |
| FY25 Q1 | 10.3% |
| FY25 Q2 | 8.3% |
| FY25 Q3 | 7.2% |
| FY25 Q4 | 5.5% |
| FY26 Q1 | 6.8% |
| FY26 Q2 | 9.1% |
| FY26 Q3 | 8.8% |
Source: SEC EDGAR filings. Retrieved November 3, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY23 Q4 | 28.3% |
| FY24 Q1 | 29.7% |
| FY24 Q2 | 36.1% |
| FY24 Q3 | 47.4% |
| FY24 Q4 | 35.8% |
| FY25 Q1 | 36.9% |
| FY25 Q2 | 36.9% |
| FY25 Q3 | 31.7% |
| FY25 Q4 | 43.2% |
| FY26 Q1 | 35.9% |
| FY26 Q2 | 40.6% |
| FY26 Q3 | 36.4% |
| Fiscal year | 2009 Dec 2009 | 2010 Dec 2010 | 2011 Dec 2011 | 2012 Dec 2012 | 2013 Dec 2013 | 2014 Dec 2014 | 2015 Dec 2015 | 2016 Dec 2016 | 2017 Dec 2017 | 2018 Dec 2018 | 2019 Dec 2019 | 2020 Dec 2020 | 2021 Dec 2021 | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 | LTM Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||
| Revenue | 7.5 | 9.6 | 10.2 | 10.3 | 11.2 | 12.3 | 12.2 | 11.8 | 12.2 | 12.9 | 13.1 | 12.0 | 13.4 | 14.3 | 16.1 | 17.9 | 18.9 | 20.1 |
| Net income | 0.7 | 1.0 | 1.1 | 1.0 | 1.3 | 1.6 | 1.6 | 1.3 | 1.5 | 2.1 | 1.9 | 1.5 | 3.4 | 3.1 | 2.6 | 3.4 | 3.6 | 4.2 |
| Diluted EPS | $2.95 | $3.77 | $4.53 | $4.62 | $6.44 | $8.30 | $8.48 | $7.81 | $9.44 | $14.20 | $13.92 | $12.20 | $28.48 | $27.70 | $23.71 | $33.05 | $36.28 | $44.39 |
| Growth (year on year) | ||||||||||||||||||
| Revenue | +6.2% | +27.1% | +6.9% | +0.2% | +9.5% | +9.5% | −0.8% | −3.0% | +2.9% | +6.1% | +1.4% | −8.7% | +12.0% | +7.1% | +12.3% | +11.4% | +5.5% | +8.8% |
| Net income | — | +37.0% | +12.8% | −7.8% | +29.6% | +21.4% | −3.5% | −15.9% | +12.7% | +41.8% | −9.8% | −19.0% | +122.8% | −7.8% | −18.8% | +33.1% | +4.8% | +14.8% |
| Diluted EPS | — | +27.8% | +20.2% | +2.0% | +39.4% | +28.9% | +2.2% | −7.9% | +20.9% | +50.4% | −2.0% | −12.4% | +133.4% | −2.7% | −14.4% | +39.4% | +9.8% | +21.8% |
| Margins | ||||||||||||||||||
| Net margin | 9.6% | 10.3% | 10.9% | 10.0% | 11.9% | 13.2% | 12.8% | 11.1% | 12.2% | 16.2% | 14.4% | 12.8% | 25.5% | 22.0% | 15.9% | 19.0% | 18.8% | 20.7% |
| Free-cash-flow margin | −18.6% | 17.9% | 18.8% | 13.3% | 11.2% | 18.6% | 21.0% | 18.9% | 11.2% | 18.8% | 16.8% | 37.4% | 23.9% | 29.5% | 28.0% | 35.8% | 43.2% | 36.4% |
| Cash flow | ||||||||||||||||||
| Cash from operations | −1.3 | 1.8 | 2.2 | 1.5 | 1.4 | 2.4 | 2.7 | 2.3 | 1.5 | 2.6 | 2.3 | 4.6 | 3.3 | 4.4 | 4.7 | 6.6 | 8.3 | 7.5 |
| Capital spending | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Free cash flow | −1.4 | 1.7 | 1.9 | 1.4 | 1.3 | 2.3 | 2.6 | 2.2 | 1.4 | 2.4 | 2.2 | 4.5 | 3.2 | 4.2 | 4.5 | 6.4 | 8.2 | 7.3 |
| Stock-based pay | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Free cash flow after stock pay | −1.6 | 1.6 | 1.8 | 1.2 | 1.1 | 2.2 | 2.4 | 2.1 | 1.2 | 2.3 | 2.1 | 4.3 | 3.1 | 4.1 | 4.3 | 6.2 | 8.0 | 7.1 |
| Balance sheet | ||||||||||||||||||
| Cash | 3.1 | 2.9 | 2.8 | 2.4 | 2.6 | 2.6 | 2.4 | 2.3 | 5.1 | 5.9 | 6.2 | 8.9 | 9.6 | 8.8 | 8.6 | 9.5 | 11.2 | 10.1 |
| Total debt | 1.9 | 3.1 | 0.0 | 2.9 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net debt (negative = net cash) | −1.2 | 0.2 | −2.8 | 0.5 | −2.6 | −2.6 | −2.4 | −2.3 | −5.1 | −5.9 | −2.9 | −5.9 | −9.6 | −8.8 | −8.6 | −9.5 | −11.2 | −10.1 |
| Diluted shares | 244m | 262m | 246m | 223m | 207m | 195m | 184m | 168m | 157m | 148m | 136m | 126m | 120m | 114m | 108m | 103m | 98m | 94m |
| Returned to shareholders | ||||||||||||||||||
| Dividends | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 |
| Buybacks | 0.0 | 0.6 | 1.5 | 1.4 | 1.6 | 1.6 | 1.7 | 1.7 | 1.5 | 1.6 | 1.9 | 1.4 | 2.0 | 2.0 | 2.1 | 2.4 | 2.9 | 3.5 |
| Total returned | 0.2 | 0.8 | 1.7 | 1.7 | 2.0 | 2.0 | 2.2 | 2.2 | 2.0 | 2.1 | 2.4 | 1.9 | 2.5 | 2.5 | 2.7 | 3.0 | 3.5 | 4.1 |
| Quarter | 2024 Q4 Dec 2024 | 2025 Q1 Mar 2025 | 2025 Q2 Jun 2025 | 2025 Q3 Sept 2025 | 2025 Q4 Dec 2025 | 2026 Q1 Mar 2026 | 2026 Q2 Jun 2026 | 2026 Q3 Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 4,649 | 4,481 | 4,490 | 4,893 | 5,047 | 4,886 | 5,013 | 5,191 |
| Net income | 1,071 | 583 | 1,060 | 912 | 1,008 | 915 | 1,113 | 1,126 |
| Diluted EPS | $10.52 | $5.83 | $10.73 | $9.33 | $10.45 | $9.68 | $11.98 | $12.32 |
| Growth (year on year) | ||||||||
| Revenue | +16.5% | +3.6% | +2.2% | +7.3% | +8.6% | +9.0% | +11.6% | +6.1% |
| Net income | +184.1% | −41.1% | +27.9% | +78.5% | −5.9% | +56.9% | +5.0% | +23.5% |
| Diluted EPS | +194.7% | −38.4% | +33.8% | +86.6% | −0.7% | +66.0% | +11.6% | +32.0% |
| Margins | ||||||||
| Net margin | 23.0% | 13.0% | 23.6% | 18.6% | 20.0% | 18.7% | 22.2% | 21.7% |
| Free-cash-flow margin | 7.0% | 36.8% | 38.4% | 44.1% | 52.0% | 8.8% | 56.8% | 27.5% |
| Cash flow | ||||||||
| Cash from operations | 383 | 1,686 | 1,764 | 2,204 | 2,669 | 459 | 2,886 | 1,471 |
| Capital spending | 58 | 36 | 38 | 44 | 44 | 29 | 37 | 42 |
| Free cash flow | 325 | 1,650 | 1,726 | 2,160 | 2,625 | 430 | 2,849 | 1,429 |
| Stock-based pay | 55 | 49 | 46 | 50 | 61 | 39 | 50 | 54 |
| Free cash flow after stock pay | 270 | 1,601 | 1,680 | 2,110 | 2,564 | 391 | 2,799 | 1,375 |
| Last 12 months unless stated | AMP | KKR | BNY | BX | STT | BLK | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $20.1bn | $21.3bn | $22.0bn | $16.1bn | $15.5bn | $27.3bn | $858m |
| Revenue growth, last 12 months | 8.8% | 31.1% | 11.2% | 17.2% | 13.3% | 95.6% | 17.2% |
| Revenue growth, 3-year average | 8.9% | 24.2% | 8.4% | 32.3% | 8.8% | — | 10.2% |
| Revenue growth, latest quarter | 6.1% | 12.5% | 11.7% | 35.9% | 12.9% | 30.6% | 14.4% |
| Net margin | 20.7% | 14.8% | 29.8% | 21.8% | 23.8% | 24.1% | 15.2% |
| Cash from operations / revenue | 37.2% | 11.7% | 42.7% | 34.7% | −14.0% | 14.4% | 26.4% |
| Free-cash-flow margin | 36.4% | 12.6% | 32.5% | 34.1% | −24.1% | 12.9% | 21.9% |
| Free-cash-flow margin, 3-year average | 38.5% | 26.6% | 5.7% | 32.1% | −31.0% | — | 17.6% |
| Stock pay / revenue | 1.0% | 3.6% | 0.0% | 9.8% | — | 5.4% | 3.7% |
| Change in share count | −5.8% | — | −3.8% | 1.9% | −3.4% | 6.6% | −0.2% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 8.8% | 17.2% | 30 of 43 |
| Change in growth rate Growth | -0.4pp | +1.0pp | 31 of 43 |
| Net margin Profitability | 20.7% | 15.2% | 21 of 43 |
| Stock pay as % of revenue Cash generation | 1.0% | 4.3% | 5 of 40 |
| Change in share count Balance sheet | -5.8% | -0.3% | 3 of 33 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | YoY |
|---|---|---|
| Investment Advice | $11.1B | ▲ 9.5% |
| Distribution Service | $2.1B | ▲ 2.8% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Ameriprise Financial's 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Blackrock, Inc. | $3.6B | 7.9M | 10.1% | ▼ 8.0% |
| Vanguard Capital Management LLC | $2.7B | 5.9M | 7.5% | ▼ 0.5% |
| Vanguard Portfolio Management LLC | $2.4B | 5.2M | 6.6% | ▼ 1.5% |
| State Street Corp | $2.1B | 4.7M | 6.0% | ▲ 1.7% |
| Geode Capital Management, LLC | $1.3B | 2.8M | 3.5% | ▼ 4.1% |
| Aristotle Capital Management, LLC | $956M | 2.1M | 2.7% | ▼ 5.8% |
| Morgan Stanley | $800M | 1.7M | 2.2% | ▼ 13.2% |
| Goldman Sachs Group Inc | $754M | 1.6M | 2.1% | ▲ 12.6% |
| Nuveen, LLC | $684M | 1.5M | 1.9% | ▼ 0.6% |
| AQR Capital Management LLC | $607M | 1.3M | 1.7% | ▼ 10.2% |
| Norges Bank | $592M | 1.3M | 1.6% | — |
| Boston Partners | $547M | 1.2M | 1.5% | ▲ 3.2% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Ameriprise Financial's complete shareholder register. Values are as reported by the filers ; 6 inconsistently scaled filing rows were excluded.
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Brockman Dawn M. SVP AND CONTROLLER | August 10, 2026 | Sell | 472 | $558.93 | $263,815 |
| Mcgraw Deirdre Davey EVP Mktg, Strat. & Comms. | August 6, 2026 | Sell | 2,400 | $558.28 | $1.3M |
| Williams William Jerryl Pres, Wealth Mgmt Advisor Grp | July 28, 2026 | Sell | 908 | $541.90 | $492,045 |
| Williams William Jerryl Pres, Wealth Mgmt Advisor Grp | July 28, 2026 | Sell | 3,200 | $540.07 | $1.7M |
| Williams William Jerryl Pres, Wealth Mgmt Advisor Grp | July 28, 2026 | Sell | 4,102 | $538.23 | $2.2M |
| Berman Walter Stanley EXECUTIVE VP AND CFO | July 28, 2026 | Sell | 422 | $549.76 | $231,998 |
| Berman Walter Stanley EXECUTIVE VP AND CFO | July 28, 2026 | Sell | 10,590 | $548.92 | $5.8M |
| Cracchiolo James M CHAIRMAN AND CEO | July 28, 2026 | Sell | 1,900 | $546.67 | $1M |
| Cracchiolo James M CHAIRMAN AND CEO | July 28, 2026 | Sell | 16,120 | $545.28 | $8.8M |
| Williams William Jerryl Pres, Wealth Mgmt Advisor Grp | July 27, 2026 | Sell | 6 | $537.61 | $3,226 |
| Williams William Jerryl Pres, Wealth Mgmt Advisor Grp | July 27, 2026 | Sell | 7,888 | $537.08 | $4.2M |
| Smyth Gerard P. EVP & Hd. of Tech. & Serv. Del | May 14, 2026 | Sell | 6,255 | $472.52 | $3M |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
In the last 12 months, 2 members of Congress disclosed 0 purchases and 2 sales of Ameriprise Financial shares.
Next expected around January 28, 2027 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
